請用此 Handle URI 來引用此文件:
https://scholars.lib.ntu.edu.tw/handle/123456789/517580
標題:
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial